{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:05:37Z","timestamp":1791644737182,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.jaut.2014.02.012","type":"journal-article","created":{"date-parts":[[2014,4,29]],"date-time":"2014-04-29T10:00:39Z","timestamp":1398765639000},"page":"33-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":161,"special_numbering":"C","title":["Altered subcellular localization of IL-33 leads to non-resolving lethal inflammation"],"prefix":"10.1016","volume":"55","author":[{"given":"Juliana","family":"Bessa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claas Aiko","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"de Vera Mudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Schlicht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan H.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Cote-Sierra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2014.02.012_bib1","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nature01320","article-title":"Points of control in inflammation","volume":"420","author":"Nathan","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2014.02.012_bib2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nri2215","article-title":"How dying cells alert the immune system to danger","volume":"8","author":"Kono","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaut.2014.02.012_bib3","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2010.02.029","article-title":"Nonresolving inflammation","volume":"140","author":"Nathan","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2014.02.012_bib4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0002-9440(10)63631-0","article-title":"Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules","volume":"163","author":"Baekkevold","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaut.2014.02.012_bib5","doi-asserted-by":"crossref","first-page":"e3331","DOI":"10.1371\/journal.pone.0003331","article-title":"The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in\u00a0vivo: a novel \u2018alarmin\u2019?","volume":"3","author":"Moussion","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2014.02.012_bib6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.immuni.2009.05.007","article-title":"Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases","volume":"31","author":"Luthi","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2014.02.012_bib7","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/all.12004","article-title":"Interleukin-33 in allergy","volume":"67","author":"Ohno","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaut.2014.02.012_bib8","doi-asserted-by":"crossref","first-page":"11489","DOI":"10.1073\/pnas.1003988107","article-title":"Systemically dispersed innate IL-13-expressing cells in type 2 immunity","volume":"107","author":"Price","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2014.02.012_bib9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nri2692","article-title":"Disease-associated functions of IL-33: the new kid in the IL-1 family","volume":"10","author":"Liew","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaut.2014.02.012_bib10","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/exd.12027","article-title":"IL-33 is secreted by psoriatic keratinocytes and induces pro-inflammatory cytokines via keratinocyte and mast cell activation","volume":"21","author":"Balato","year":"2012","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaut.2014.02.012_bib11","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/jid.2011.446","article-title":"IL-33 and ST2 in atopic dermatitis: expression profiles and modulation by triggering factors","volume":"132","author":"Savinko","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaut.2014.02.012_bib12","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1684\/ecn.2012.0320","article-title":"Mechanisms of IL-33 processing and secretion: differences and similarities between IL-1 family members","volume":"23","author":"Lefrancais","year":"2012","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.jaut.2014.02.012_bib13","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1586\/1744666X.2013.814428","article-title":"The alarmin functions of high-mobility group box-1 and IL-33 in the pathogenesis of systemic lupus erythematosus","volume":"9","author":"Yu","year":"2013","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaut.2014.02.012_bib14","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2353\/ajpath.2008.080014","article-title":"Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation","volume":"173","author":"Kuchler","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaut.2014.02.012_bib15","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2222.2009.03384.x","article-title":"IL-33: a tissue derived cytokine pathway involved in allergic inflammation and asthma","volume":"40","author":"Smith","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaut.2014.02.012_bib16","doi-asserted-by":"crossref","first-page":"e11944","DOI":"10.1371\/journal.pone.0011944","article-title":"IL-33 is produced by mast cells and regulates IgE-dependent inflammation","volume":"5","author":"Hsu","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2014.02.012_bib17","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.4049\/jimmunol.1101977","article-title":"Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain","volume":"188","author":"Pichery","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.02.012_bib18","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.0606854104","article-title":"IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in\u00a0vivo","volume":"104","author":"Carriere","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2014.02.012_bib19","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2014.02.012_bib20","doi-asserted-by":"crossref","first-page":"9021","DOI":"10.1073\/pnas.0812690106","article-title":"The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1","volume":"106","author":"Cayrol","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2014.02.012_bib21","doi-asserted-by":"crossref","first-page":"19420","DOI":"10.1074\/jbc.M901744200","article-title":"Interleukin-33 is biologically active independently of caspase-1 cleavage","volume":"284","author":"Talabot-Ayer","year":"2009","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jaut.2014.02.012_bib22","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.bbrc.2009.12.107","article-title":"Caspase 3 inactivates biologically active full length interleukin-33 as a classical cytokine but does not prohibit nuclear translocation","volume":"391","author":"Ali","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jaut.2014.02.012_bib23","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1084\/jem.191.6.1069","article-title":"T1\/ST2-deficient mice demonstrate the importance of T1\/ST2 in developing primary T helper cell type 2 responses","volume":"191","author":"Townsend","year":"2000","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaut.2014.02.012_bib24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.it.2012.04.005","article-title":"Interleukin-33 and the function of innate lymphoid cells","volume":"33","author":"Mirchandani","year":"2012","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaut.2014.02.012_bib25","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/embor.2008.145","article-title":"Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket","volume":"9","author":"Roussel","year":"2008","journal-title":"EMBO Rep"},{"key":"10.1016\/j.jaut.2014.02.012_bib26","unstructured":"Oboki K, Ohno T, Kajiwara N, Arae K, Morita H, Ishii A. et\u00a0al. IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.jaut.2014.02.012_bib27","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/030098589002700409","article-title":"Acidophilic macrophage pneumonia in laboratory mice","volume":"27","author":"Murray","year":"1990","journal-title":"Vet Pathol"},{"key":"10.1016\/j.jaut.2014.02.012_bib28","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1084\/jem.20050548","article-title":"Identification of eosinophil lineage-committed progenitors in the murine bone marrow","volume":"201","author":"Iwasaki","year":"2005","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaut.2014.02.012_bib29","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.4049\/jimmunol.179.4.2551","article-title":"IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex","volume":"179","author":"Chackerian","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.02.012_bib30","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/art.24305","article-title":"Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis","volume":"60","author":"Palmer","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.jaut.2014.02.012_bib31","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1136\/gutjnl-2011-301785","article-title":"Neutralisation of the interleukin-33\/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice","volume":"62","author":"Sedhom","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2014.02.012_bib32","doi-asserted-by":"crossref","first-page":"9773","DOI":"10.1073\/pnas.0901206106","article-title":"The cytokine interleukin-33 mediates anaphylactic shock","volume":"106","author":"Pushparaj","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2014.02.012_bib33","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.4049\/jimmunol.179.4.2051","article-title":"Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells","volume":"179","author":"Allakhverdi","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.02.012_bib34","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1189\/jlb.0407200","article-title":"IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals","volume":"82","author":"Ho","year":"2007","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.jaut.2014.02.012_bib35","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/labinvest.3700663","article-title":"IL-33 can promote survival, adhesion and cytokine production in human mast cells","volume":"87","author":"Iikura","year":"2007","journal-title":"Lab Invest"},{"key":"10.1016\/j.jaut.2014.02.012_bib36","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1182\/blood-2008-05-157818","article-title":"Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33","volume":"113","author":"Pecaric-Petkovic","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2014.02.012_bib37","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1084\/jem.172.5.1425","article-title":"Eosinophilia in transgenic mice expressing interleukin 5","volume":"172","author":"Dent","year":"1990","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaut.2014.02.012_bib38","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1084\/jem.173.2.429","article-title":"Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production","volume":"173","author":"Tominaga","year":"1991","journal-title":"J\u00a0Exp Med"},{"issue":"5","key":"10.1016\/j.jaut.2014.02.012_bib39","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/mi.2012.130","article-title":"Potential autocrine regulation of interleukin-33\/ST2 signaling of dendritic cells in allergic inflammation","volume":"6","author":"Su","year":"2013","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaut.2014.02.012_bib40","doi-asserted-by":"crossref","first-page":"8017","DOI":"10.1073\/pnas.0912678107","article-title":"Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1\/Th2 driven enteritis","volume":"107","author":"Pastorelli","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2014.02.012_bib41","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.imlet.2009.11.001","article-title":"IL-33 is upregulated in colonocytes of ulcerative colitis","volume":"128","author":"Seidelin","year":"2010","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jaut.2014.02.012_bib42","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00535-010-0245-1","article-title":"Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis","volume":"45","author":"Kobori","year":"2010","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jaut.2014.02.012_bib43","doi-asserted-by":"crossref","first-page":"10913","DOI":"10.1073\/pnas.0801898105","article-title":"IL-33 exacerbates antigen-induced arthritis by activating mast cells","volume":"105","author":"Xu","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2014.02.012_bib44","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00296-011-1854-6","article-title":"Sustained elevation of interleukin-33 in sera and synovial fluids from patients with rheumatoid arthritis non-responsive to anti-tumor necrosis factor: possible association with persistent IL-1beta signaling and a poor clinical response","volume":"32","author":"Matsuyama","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jaut.2014.02.012_bib45","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.20071868","article-title":"IL-33 reduces the development of atherosclerosis","volume":"205","author":"Miller","year":"2008","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaut.2014.02.012_bib46","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(08)61452-X","article-title":"Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease","volume":"372","author":"Anderson","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2014.02.012_bib47","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/j.jss.2010.04.004","article-title":"Up-regulation of interleukin 33 and soluble ST2 serum levels in liver failure","volume":"163","author":"Roth","year":"2010","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.jaut.2014.02.012_bib48","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","article-title":"Immunological and inflammatory functions of the interleukin-1 family","volume":"27","author":"Dinarello","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaut.2014.02.012_bib49","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1073\/pnas.1115884109","article-title":"IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G","volume":"109","author":"Lefrancais","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.jaut.2014.02.012_bib50","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/icb.2013.25","article-title":"The multifunctional alarmin HMGB1 with roles in the pathophysiology of sepsis and cancer","volume":"91","author":"Diener","year":"2013","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jaut.2014.02.012_bib51","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fimmu.2013.00167","article-title":"New insights in the Immunobiology of IL-1 family members","volume":"4","author":"van de Veerdonk","year":"2013","journal-title":"Front Immunol"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841114000638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841114000638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:10:54Z","timestamp":1760256654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841114000638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":51,"alternative-id":["S0896841114000638"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2014.02.012","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered subcellular localization of IL-33 leads to non-resolving lethal inflammation","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2014.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}